Legal Representation
Attorney
David J. Davis
USPTO Deadlines
Application History
27 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jan 19, 2006 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | Loading... |
| Jan 19, 2006 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Apr 20, 2005 | EX5G | S | SOU EXTENSION 5 GRANTED | Loading... |
| Apr 20, 2005 | EXT5 | S | SOU EXTENSION 5 FILED | Loading... |
| Apr 20, 2005 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Nov 9, 2004 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
| Oct 22, 2004 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
| Oct 22, 2004 | I | PAPER RECEIVED | Loading... | |
| May 6, 2004 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Apr 26, 2004 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| May 4, 2004 | CFIT | O | CASE FILE IN TICRS | Loading... |
| Apr 26, 2004 | I | PAPER RECEIVED | Loading... | |
| Dec 8, 2003 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Nov 10, 2003 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Nov 10, 2003 | I | PAPER RECEIVED | Loading... | |
| Jun 19, 2003 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| May 12, 2003 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| May 12, 2003 | I | PAPER RECEIVED | Loading... | |
| Nov 12, 2002 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Aug 20, 2002 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jul 31, 2002 | NPUB | O | NOTICE OF PUBLICATION | Loading... |
| Jun 4, 2002 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Mar 18, 2002 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Dec 13, 2001 | CNFR | O | FINAL REFUSAL MAILED | Loading... |
| Sep 17, 2001 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jul 13, 2001 | CNRT | F | NON-FINAL ACTION MAILED | Loading... |
| Jul 13, 2001 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Detailed Classifications
Class 001
Molecules and antibodies for scientific research use in the treatment of cancer
First Use Anywhere:
0
First Use in Commerce:
0
Class 005
Pharmaceutical preparations and sanitary preparations, namely, small molecules, antibodies and antibody derivatives used for medical therapeutic uses in the treatment of cancer; diagnostic agents, namely, medical diagnostic reagents used in diagnosis of cancer
First Use Anywhere:
0
First Use in Commerce:
0
Class 042
Research in the field of biotechnology and development of pharmaceutical preparations and medicine
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
001
005
042